Literature DB >> 4451358

In vitro studies with cefazolin.

M Motley, S Shadomy.   

Abstract

Susceptibilities of 259 isolates of pathogenic bacteria to cefazolin were measured by broth and agar dilution procedures. Beta-hemolytic streptococci were inhibited by 0.25 mug/ml, whereas Staphylococcus aureus and alphahemolytic streptococci were inhibited by 2.0 mug/ml. Enterococci were resistant to less than 32 mug/ml. Wide variation was seen with gram-negative species. Most isolates of Klebsiella species and Proteus mirabilis were inhibited by 4.0 or 8.0 mug/ml. Escherichia coli were less susceptible, and most isolates of Pseudomonas aeruginosa, Serratia species, and Enterobacter species were resistant to 128 mug/ml.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451358      PMCID: PMC444750          DOI: 10.1128/AAC.6.6.856

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Bactericidal activity and pharmacology of cefazolin.

Authors:  M G Bergeron; J L Brusch; M Barza; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

2.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

3.  Evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  L B Reller; W W Karney; H N Beaty; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  3 in total
  4 in total

1.  Penetration of cefazolin into pleural fluid.

Authors:  D R Cole; J Pung
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.

Authors:  M Fukasawa; H Noguchi; T Okuda; T Komatsu; K Yano
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.